Physician profile
Janet Bilder
NPI 1326451030
$1,304.74
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $32.15 · 2022: $51.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $218.57 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.39 | 2019 | |
| Lilly USA, LLC | $162.54 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $146.04 | 2019 | |
| Glaxosmithkline, LLC. | $132.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $132.48 | 2019 | |
| Pfizer INC. | $94.91 | 2019 | |
| Amgen INC. | $84.40 | 2019 | |
| Amarin Pharma, INC. | $42.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.43 | 2019 | |
| Adlon Therapeutics L.P. | $21.71 | 2019 | |
| Ironwood Pharmaceuticals, INC | $17.60 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.49 | 2019 | |
| Kaleo, INC. | $15.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Bilder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.